Want to join the conversation?
$MKC expects to grow sales by 4-6% on a constant currency basis in 2016 compared to 2015, helped by increases in volume and product mix, pricing actions to offset a projected increase in material costs and incremental sales from the completed 2015 acquisitions. The company expects this range to be reduced as a result of unfavorable FX rates.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.